ABCC7 p.Gly330Cys

ClinVar: c.988G>T , p.Gly330* D , Pathogenic
CF databases: c.988G>T , p.Gly330* D , CF-causing
Predicted by SNAP2: A: D (80%), C: D (75%), D: D (71%), E: D (80%), F: D (91%), H: D (85%), I: D (85%), K: D (80%), L: D (85%), M: D (85%), N: N (82%), P: D (91%), Q: D (85%), R: D (91%), S: N (53%), T: N (57%), V: D (85%), W: D (91%), Y: D (91%),
Predicted by PROVEAN: A: N, C: D, D: N, E: N, F: D, H: N, I: D, K: N, L: D, M: D, N: N, P: N, Q: N, R: N, S: N, T: N, V: N, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Beck EJ, Yang Y, Yaemsiri S, Raghuram V
Conformational changes in a pore-lining helix coupled to cystic fibrosis transmembrane conductance regulator channel gating.
J Biol Chem. 2008 Feb 22;283(8):4957-66. Epub 2007 Dec 3., 2008-02-22 [PMID:18056267]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Alexander C, Ivetac A, Liu X, Norimatsu Y, Serrano JR, Landstrom A, Sansom M, Dawson DC
Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore.
Biochemistry. 2009 Oct 27;48(42):10078-88., 2009-10-27 [PMID:19754156]

Abstract [show]
Comments [show]
Sentences [show]